Immunosuppressive treatment protects against angiotensin II-induced renal damageMUTTER, Dominik N; SHAGDARSUREN, Erdenechimeg; VIEDT, Christiane et al.The American journal of pathology. 2002, Vol 161, Num 5, pp 1679-1693, issn 0002-9440, 15 p.Article

Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient miceBEA, Florian; KREUZER, Joerg; PREUSCH, Michael et al.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 12, pp 2787-2792, issn 1079-5642, 6 p.Article

Decreased plasma lipoprotein lipase in hypoadiponectinemia: An association independent of systemic inflammation and insulin resistanceVON EYNATTEN, Maximilian; SCHNEIDER, Jochen G; NAWROTH, Peter P et al.Diabetes care. 2004, Vol 27, Num 12, pp 2925-2929, issn 0149-5992, 5 p.Article

Low hepatic lipase activity is a novel risk factor for coronary artery diseaseDUGI, Klaus A; BRANDAUER, Karin; BAHNER, Malte L et al.Circulation (New York, N.Y.). 2001, Vol 104, Num 25, pp 3057-3062, issn 0009-7322Article

Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery diseaseDUGI, Klaus A; SCHMIDT, Nikolaus; BRANDAUER, Karin et al.Atherosclerosis. 2002, Vol 163, Num 1, pp 127-134, issn 0021-9150Article

The proline 12 alanine substitution in the peroxisome proliferator-activated receptor-γ2 gene is associated with lower lipoprotein lipase activity in vivoSCHNEIDER, Jochen; KREUZER, Joerg; HAMANN, Andreas et al.Diabetes (New York, NY). 2002, Vol 51, Num 3, pp 867-870, issn 0012-1797Article